Pluri Inc. — Director's Dealing 2014

Sep 16, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2014-09-16

Reporting Person: YANAY YAKY (COO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-16	Common Stock	P	10000	$2.85	Acquired	1079616	Direct

Footnotes

F1: The purchase was effected on the Tel Aviv Stock Exchange in New Israeli Shekels (NIS) for per share purchase price of NIS 10.33, which per share purchase price has been reported on this Form 4 in U.S. dollars based on an exchange rate of NIS 3.626 per U.S. dollar.